Oral contraceptive pills (OCPs) have some strong advantages over more traditional types of contraception, including their consistently high contraceptive effect as well as multiple additional positive side effects. OCPs went through decades of intense pharmaceutical development and current formulas are well optimized - however, a handful of their negative side effects remain, including some that affect cardiovascular system, for example higher risk of hypertension, venous thromboembolism and increased arterial stiffness. The gold standard for arterial stiffness assessment is currently applanation tonometry, a method that relies on arterial pulse wave velocity measurement (PWV). Another possible method for arterial stiffness measurement is the use of the VaSera device, which measures cardio-ankle vascular index (CAVI). The aim of this study was to discover the effect of OCPs use on selected cardiovascular parameters related to arterial stiffness. We measured these cardiovascular parameters in the OCPs using group (OCP) and in the control group (CTRL) using applanation tonometer Sphygmocor and the VaSera device. Comparison of the data from both groups showed us significantly increased diastolic blood pressure (DBP) and carotid-radial pulse wave velocity (crPWV) as well as significantly lower subendocardial viability index (SVI) in the OCP. These results imply a negative effect of hormonal contraceptives on the cardiovascular system with most of the negative changes affecting the peripheral arteries. Despite this evidence supporting the hypothesis of OCPs having a negative effect on cardiovascular health, further research is necessary.

Department of Physiology Faculty of Medicine Masaryk University Brno Czech Republic

See more in PubMed

Information NC for B. Pike USNL of M 8600 R, MD B, Usa 20894. Contraception: Hormonal contraceptives [Internet] Inf Internet Institute for Quality and Efficiency in Health Care (IQWiG) 2017. [cited 2022 Apr 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441576/

Pletzer BA, Kerschbaum HH. 50 years of hormonal contraception-time to find out, what it does to our brain. Front Neurosci. 2014;8:256. doi: 10.3389/fnins.2014.00256. PubMed DOI PMC

United Nations. Contraceptive Use by Method 2019: Data Booklet [Internet] UN; 2019. [cited 2021 Oct 19]. Available from: https://www.un-ilibrary.org/content/books/9789210046527.

Williams NM, Randolph M, Rajabi-Estarabadi A, Keri J, Tosti A. Hormonal contraceptives and dermatology. Am J Clin Dermatol. 2021;22:69–80. doi: 10.1007/s40257-020-00557-5. PubMed DOI

Chen JT, Kotani K. Oral contraceptive therapy increases oxidative stress in pre-menopausal women. Int J Prev Med. 2012;3:893–896. doi: 10.4103/2008-7802.104862. PubMed DOI PMC

Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO, Zikan M, Dusek L. Hormonal contraception and risk of cancer. Hum Reprod Update. 2010;16:631–650. doi: 10.1093/humupd/dmq022. PubMed DOI

Wang Q, Würtz P, Auro K, Morin-Papunen L, Kangas AJ, Soininen P, Tiainen M, et al. Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence. Int J Epidemiol. 2016;45:1445–1457. doi: 10.1093/ije/dyw147. PubMed DOI PMC

Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol. 2009;53:221–231. doi: 10.1016/j.jacc.2008.09.042. PubMed DOI PMC

Hickson SS, Miles KL, McDonnell BJ, Yasmin, Cockcroft JR, Wilkinson IB, McEniery CM ENIGMA Study Investigators. Use of the oral contraceptive pill is associated with increased large artery stiffness in young women: the ENIGMA study. J Hypertens. 2011;29:1155–1159. doi: 10.1097/HJH.0b013e328346a5af. PubMed DOI

Cauci S, Xodo S, Buligan C, Colaninno C, Barbina M, Barbina G, Francescato MP. Oxidative stress is increased in combined oral contraceptives users and is positively associated with high-sensitivity C-reactive protein. Molecules. 2021;26:1070. doi: 10.3390/molecules26041070. PubMed DOI PMC

Cecelja M, Chowienczyk P. Role of arterial stiffness in cardiovascular disease. JRSM Cardiovasc Dis. 2012;1:cvd.2012.012016. doi: 10.1258/cvd.2012.012016. PubMed DOI PMC

Boutouyrie P, Bruno R-M. The clinical significance and application of vascular stiffness measurements. Am J Hypertens. 2019;32:4–11. doi: 10.1093/ajh/hpy145. PubMed DOI

Soska V, Frantisova M, Dobsak P, Dusek L, Jarkovsky J, Novakova M, Shirai K, et al. Cardio-ankle vascular index in subjects with dyslipidaemia and other cardiovascular risk factors. J Atheroscler Thromb. 2013;20:443–451. doi: 10.5551/jat.15420. PubMed DOI

Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update. 2006;12:169–178. doi: 10.1093/humupd/dmi046. PubMed DOI

Cianci A, De Leo V. Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives. (Article in Italian) Minerva Ginecol. 2007;59:415–425. PubMed

Rübig A. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties. Climacteric. 2003;6(Suppl 3):49–54. PubMed

Silva-Bermudez LS, Toloza FJK, Perez-Matos MC, de Souza RJ, Banfield L, Vargas-Villanueva A, Mendivil CO. Effects of oral contraceptives on metabolic parameters in adult premenopausal women: a meta-analysis. Endocr Connect. 2020;9:978–998. doi: 10.1530/EC-20-0423. PubMed DOI PMC

Yildizhan R, Yildizhan B, Adali E, Yoruk P, Birol F, Suer N. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure. Arch Gynecol Obstet. 2009;280:255–261. doi: 10.1007/s00404-008-0907-x. PubMed DOI

Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause. 2002;9:6–15. doi: 10.1097/00042192-200201000-00003. PubMed DOI

Enea C, Laffetas P, Pichon A, Delpech N. Arterial stiffness and hemodynamics in young women: the effects of oral contraceptive intake and physical habits. Int J Environ Res Public Health. 2021;18:3393. doi: 10.3390/ijerph18073393. PubMed DOI PMC

Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–237. doi: 10.1038/s41581-019-0244-2. PubMed DOI PMC

Beilin LJ, Puddey IB, Burke V. Lifestyle and hypertension. Am J Hypertens. 1999;12:934–945. doi: 10.1016/S0895-7061(99)00057-6. PubMed DOI

Priest SE, Shenouda N, MacDonald MJ. Effect of sex, menstrual cycle phase, and monophasic oral contraceptive pill use on local and central arterial stiffness in young adults. Am J Physiol Heart Circ Physiol. 2018;315:H357–H365. doi: 10.1152/ajpheart.00039.2018. PubMed DOI PMC

Yu A, Giannone T, Scheffler P, Doonan RJ, Egiziano G, Gomez Y-H, Papaioannou TG, Daskalopoulou SS. The effect of oral contraceptive pills and the natural menstrual cYCLe on arterial stiffness and hemodynamICs (CYCLIC) J Hypertens. 2014;32:100–107. doi: 10.1097/HJH.0000000000000012. PubMed DOI

Minson CT, Halliwill JR, Young TM, Joyner MJ. Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. Circulation. 2000;102:1473–1476. doi: 10.1161/01.CIR.102.13.1473. PubMed DOI

Kang AK, Duncan JA, Cattran DC, Floras JS, Lai V, Scholey JW, Miller JA. Effect of oral contraceptives on the renin angiotensin system and renal function. Am J Physiol Regul Integr Comp Physiol. 2001;280:R807–R813. doi: 10.1152/ajpregu.2001.280.3.R807. PubMed DOI

Milyagin VA, Filichkin DE, Shpynev KV, Shpyneva ZM, Milyagina IV. Contour analysis of central and peripheral pulse wave in healthy people and in hypertensive patients. Arter Gipertenz. 2009;15:78–85. doi: 10.18705/1607-419X-2009-15-1-78-85. DOI

Shirai K. Analysis of vascular function using the cardio-ankle vascular index (CAVI) Hypertens Res. 2011;34:684–685. doi: 10.1038/hr.2011.40. PubMed DOI

Shirai K, Saiki A, Nagayama D, Tatsuno I, Shimizu K, Takahashi M. The role of monitoring arterial stiffness with cardio-ankle vascular index in the control of lifestyle-related diseases. Pulse. 2015;3:118–133. doi: 10.1159/000431235. PubMed DOI PMC

Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet. 2018;141:287–294. doi: 10.1002/ijgo.12455. PubMed DOI PMC

Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: A bench to bedside review. Thromb Res. 2020;192:40–51. doi: 10.1016/j.thromres.2020.05.008. PubMed DOI PMC

Casey S, Lanting S, Oldmeadow C, Chuter V. The reliability of the ankle brachial index: a systematic review. J Foot Ankle Res. 2019;12:39. doi: 10.1186/s13047-019-0350-1. PubMed DOI PMC

Šudaková M, Budinskaya K, Nováková Z. Evaluation of diastolic heart function using echocardiography and pulse wave analysis in patients after anthracycline therapy. 2021 Comput Cardiol. 2021:1–4. doi: 10.23919/CinC53138.2021.9662816. DOI